Plasma Transforming Growth Factor α and Amphiregulin Protein Levels in NCIC Clinical Trials Group BR.21
Christina Addison(Ontario Institute for Cancer Research), Penelope A. Bradbury(University Health Network), Lesley Seymour(Queen's University), Keyue Ding(Ontario Institute for Cancer Research), Frances A. Shepherd(University Health Network), Aurélie Le Maître(Ontario Institute for Cancer Research), Glenwood D. Goss(Ontario Institute for Cancer Research), Ming‐Sound Tsao(Kumamoto University), Huijun Zhao(Ministry of Education of the People's Republic of China)
Cited by 55
Related Papers
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
|Journal of Thoracic Oncology|2011|4.8k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
|Journal of Clinical Oncology|2007|3.9k
Osimertinib or Platinum–Pemetrexed in <i>EGFR</i> T790M–Positive Lung Cancer
|New England Journal of Medicine|2016|3.3k
Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy
|Journal of Clinical Oncology|2004|2.4k